122 related articles for article (PubMed ID: 21801719)
1. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma.
Bahnassy AA; Zekri AR; Loutfy SA; Mohamed WS; Moneim AA; Salem SE; Sheta MM; Omar A; Al-Zawahry H
Exp Mol Pathol; 2011 Oct; 91(2):643-52. PubMed ID: 21801719
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
3. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
[TBL] [Abstract][Full Text] [Related]
5. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S
Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclins and cdks throughout murine carcinogenesis.
Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
9. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats.
Masaki T; Shiratori Y; Rengifo W; Igarashi K; Matsumoto K; Nishioka M; Hatanaka Y; Omata M
Hepatology; 2000 Oct; 32(4 Pt 1):711-20. PubMed ID: 11003614
[TBL] [Abstract][Full Text] [Related]
11. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.
Matsumoto M; Furihata M; Ishikawa T; Ohtsuki Y; Ogoshi S
Br J Cancer; 1999 Apr; 80(1-2):256-61. PubMed ID: 10390005
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma.
Ito K; Sasano H; Yoshida Y; Sato S; Yajima A
Anticancer Res; 1998; 18(3A):1661-4. PubMed ID: 9673386
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
[TBL] [Abstract][Full Text] [Related]
15. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
16. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
Choi YL; Park SH; Jang JJ; Park CK
J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
[TBL] [Abstract][Full Text] [Related]
17. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
Moore GD; Ayabe T; Kopf GS; Schultz RM
Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
[TBL] [Abstract][Full Text] [Related]
18. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
20. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]